Differential cytokine regulation by NF-κB and AP-1 in Jurkat T-cells

BMC Immunology

Volumn 11, Issue , 2010, Pages

  Khalaf, Hazem ^a   Jass, Jana ^a,b   Olsson, Per Erik ^a  

^a ÖREBRO UNIVERSITY   (Sweden)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CALCIUM IONOPHORE; CYTOKINE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN BCL 10; PROTEIN KINASE C; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR; BCL10 PROTEIN, HUMAN; IL8 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; COCARCINOGENESIS; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; DOWN REGULATION; ESCHERICHIA COLI; GENE ACTIVITY; LEUKEMIA CELL LINE; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; UPREGULATION; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; HUMAN; INFLAMMATION; METABOLISM; PROTEIN PROCESSING; TIME;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CYTOKINES; DOWN-REGULATION; ESCHERICHIA COLI; HUMANS; INFLAMMATION; INTERLEUKIN-6; INTERLEUKIN-8; JNK MITOGEN-ACTIVATED PROTEIN KINASES; JURKAT CELLS; NF-KAPPA B; PROTEIN KINASE C; PROTEIN PROCESSING, POST-TRANSLATIONAL; T-LYMPHOCYTES; TETRADECANOYLPHORBOL ACETATE; TIME FACTORS; TRANSCRIPTION FACTOR AP-1; UP-REGULATION;

EID: 77952738203     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-11-26     Document Type: Article

References (54)

1. Gonzalo JA, Lloyd CM, Kremer L, Finger E, Martinez AC, Siegelman MH, Cybulsky M, Gutierrez-Ramos JC. Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors. J Clin Invest 1996, 98:2332-45. 10.1172/JCI119045, 507684, 8941651.
2. Wang J, Shannon MF, Young IG. A role for Ets1, synergizing with AP-1 and GATA-3 in the regulation of IL-5 transcription in mouse Th2 lymphocytes. Int Immunol 2006, 18:313-23. 10.1093/intimm/dxh370, 16373364.
3. Carpagnano GE, Barnes PJ, Geddes DM, Hodson ME, Kharitonov SA. Increased leukotriene B4 and interleukin-6 in exhaled breath condensate in cystic fibrosis. Am J Respir Crit Care Med 2003, 167:1109-12. 10.1164/rccm.200203-179OC, 12684249.
4. Kube D, Sontich U, Fletcher D, Davis PB. Proinflammatory cytokine responses to P. aeruginosa infection in human airway epithelial cell lines. Am J Physiol Lung Cell Mol Physiol 2001, 280:L493-502.
5. Stecenko AA, King G, Torii K, Breyer RM, Dworski R, Blackwell TS, Christman JW, Brigham KL. Dysregulated cytokine production in human cystic fibrosis bronchial epithelial cells. Inflammation 2001, 25:145-55. 10.1023/A:1011080229374, 11403205.
6. Smith RS, Smith TJ, Blieden TM, Phipps RP. Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. Am J Pathol 1997, 151:317-22. 1858004, 9250144.
7. Wedzicha JA, Seemungal TA, MacCallum PK, Paul EA, Donaldson GC, Bhowmik A, Jeffries DJ, Meade TW. Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels. Thromb Haemost 2000, 84:210-5.
8. Breen EC, Rezai AR, Nakajima K, Beall GN, Mitsuyasu RT, Hirano T, Kishimoto T, Martinez-Maza O. Infection with HIV is associated with elevated IL-6 levels and production. J Immunol 1990, 144:480-4.
9. Ott M, Lovett JL, Mueller L, Verdin E. Superinduction of IL-8 in T cells by HIV-1 Tat protein is mediated through NF-kappaB factors. J Immunol 1998, 160:2872-80.
10. Okamoto S, Mukaida N, Yasumoto K, Rice N, Ishikawa Y, Horiguchi H, Murakami S, Matsushima K. The interleukin-8 AP-1 and kappa B-like sites are genetic end targets of FK506-sensitive pathway accompanied by calcium mobilization. J Biol Chem 1994, 269:8582-9.
11. Yasumoto K, Okamoto S, Mukaida N, Murakami S, Mai M, Matsushima K. Tumor necrosis factor alpha and interferon gamma synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-kB-like binding sites of the interleukin 8 gene. J Biol Chem 1992, 267:22506-11.
12. Harris SG, Smith RS, Phipps RP. 15-deoxy-Delta 12,14-PGJ2 induces IL-8 production in human T cells by a mitogen-activated protein kinase pathway. J Immunol 2002, 168:1372-9.
13. Ishihara K, Hirano T. IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev 2002, 13:357-68. 10.1016/S1359-6101(02)00027-8, 12220549.
14. Ginn-Pease ME, Whisler RL. Optimal NF kappa B mediated transcriptional responses in Jurkat T cells exposed to oxidative stress are dependent on intracellular glutathione and costimulatory signals. Biochem Biophys Res Commun 1996, 226:695-702. 10.1006/bbrc.1996.1416, 8831677.
15. Aifantis I, Gounari F, Scorrano L, Borowski C, von Boehmer H. Constitutive pre-TCR signaling promotes differentiation through Ca2+ mobilization and activation of NF-kappaB and NFAT. Nat Immunol 2001, 2:403-9.
16. Bassuk AG, Leiden JM. A direct physical association between ETS and AP-1 transcription factors in normal human T cells. Immunity 1995, 3:223-37. 10.1016/1074-7613(95)90092-6, 7648395.
17. Chang JH, Pratt JC, Sawasdikosol S, Kapeller R, Burakoff SJ. The small GTP-binding protein Rho potentiates AP-1 transcription in T cells. Mol Cell Biol 1998, 18:4986-93. 109083, 9710582.
18. Boise LH, Petryniak B, Mao X, June CH, Wang CY, Lindsten T, Bravo R, Kovary K, Leiden JM, Thompson CB. The NFAT-1 DNA binding complex in activated T cells contains Fra-1 and JunB. Mol Cell Biol 1993, 13:1911-9. 359505, 8441422.
19. Rooney JW, Hoey T, Glimcher LH. Coordinate and cooperative roles for NF-AT and AP-1 in the regulation of the murine IL-4 gene. Immunity 1995, 2:473-83. 10.1016/1074-7613(95)90028-4, 7749982.
20. Tsai EY, Jain J, Pesavento PA, Rao A, Goldfeld AE. Tumor necrosis factor alpha gene regulation in activated T cells involves ATF-2/Jun and NFATp. Mol Cell Biol 1996, 16:459-67. 231022, 8552071.
21. Vacca A, Felli MP, Farina AR, Martinotti S, Maroder M, Screpanti I, Meco D, Petrangeli E, Frati L, Gulino A. Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements. J Exp Med 1992, 175:637-46. 10.1084/jem.175.3.637, 2119143, 1740658.
22. Yang Y, Pares-Matos EI, Tesmer VM, Dai C, Ashworth S, Huai J, Bina M. Organization of the promoter region of the human NF-IL6 gene. Biochim Biophys Acta 2002, 1577:102-8.
23. Standiford TJ, Kunkel SL, Strieter RM. Interleukin-8: a major mediator of acute pulmonary inflammation. Reg Immunol 1993, 5:134-41.
24. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 2003, 374:1-20. 10.1042/BJ20030407, 1223585, 12773095.
25. Tilg H, Trehu E, Atkins MB, Dinarello CA, Mier JW. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 1994, 83:113-8.
26. Heasley LE, Han SY. JNK regulation of oncogenesis. Mol Cells 2006, 21:167-73.
27. Narayan P, Holt B, Tosti R, Kane LP. CARMA1 is required for Akt-mediated NF-kappaB activation in T cells. Mol Cell Biol 2006, 26:2327-36. 10.1128/MCB.26.6.2327-2336.2006, 1430296, 16508008.
28. Kanno T, Siebenlist U. Activation of nuclear factor-kappaB via T cell receptor requires a Raf kinase and Ca2+ influx. Functional synergy between Raf and calcineurin. J Immunol 1996, 157:5277-83.
29. Lorentz A, Klopp I, Gebhardt T, Manns MP, Bischoff SC. Role of activator protein 1, nuclear factor-kappaB, and nuclear factor of activated T cells in IgE receptor-mediated cytokine expression in mature human mast cells. J Allergy Clin Immunol 2003, 111:1062-8. 10.1067/mai.2003.1342, 12743571.
30. Ruland J, Mak TW. Transducing signals from antigen receptors to nuclear factor kappaB. Immunol Rev 2003, 193:93-100. 10.1034/j.1600-065X.2003.00049.x, 12752674.
31. Franklin RA, Tordai A, Patel H, Gardner AM, Johnson GL, Gelfand EW. Ligation of the T cell receptor complex results in activation of the Ras/Raf-1/MEK/MAPK cascade in human T lymphocytes. J Clin Invest 1994, 93:2134-40. 10.1172/JCI117209, 294346, 8182145.
32. Holmstrom TH, Schmitz I, Soderstrom TS, Poukkula M, Johnson VL, Chow SC, Krammer PH, Eriksson JE. MAPK/ERK signaling in activated T cells inhibits CD95/Fas-mediated apoptosis downstream of DISC assembly. Embo J 2000, 19:5418-28. 10.1093/emboj/19.20.5418, 314013, 11032809.
33. Lyakh L, Ghosh P, Rice NR. Expression of NFAT-family proteins in normal human T cells. Mol Cell Biol 1997, 17:2475-84. 232096, 9111316.
34. Macian F, Lopez-Rodriguez C, Rao A. Partners in transcription: NFAT and AP-1. Oncogene 2001, 20:2476-89. 10.1038/sj.onc.1204386, 11402342.
35. Kyriakis JM, Avruch J. Sounding the alarm: protein kinase cascades activated by stress and inflammation. J Biol Chem 1996, 271:24313-6. 10.1074/jbc.271.40.24313, 8798679.
36. Park KA, Byun HS, Won M, Yang KJ, Shin S, Piao L, Kim JM, Yoon WH, Junn E, Park J, et al. Sustained activation of protein kinase C downregulates nuclear factor-kappaB signaling by dissociation of IKK-gamma and Hsp90 complex in human colonic epithelial cells. Carcinogenesis 2007, 28:71-80. 10.1093/carcin/bgl094, 16774932.
37. Wang JE, Jorgensen PF, Almlof M, Thiemermann C, Foster SJ, Aasen AO, Solberg R. Peptidoglycan and lipoteichoic acid from Staphylococcus aureus induce tumor necrosis factor alpha, interleukin 6 (IL-6), and IL-10 production in both T cells and monocytes in a human whole blood model. Infect Immun 2000, 68:3965-70. 10.1128/IAI.68.7.3965-3970.2000, 101674, 10858210.
38. Antonsson A, Hughes K, Edin S, Grundstrom T. Regulation of c-Rel nuclear localization by binding of Ca2+/calmodulin. Mol Cell Biol 2003, 23:1418-27. 10.1128/MCB.23.4.1418-1427.2003, 141150, 12556500.
39. Opal SM, DePalo VA. Anti-inflammatory cytokines. Chest 2000, 117:1162-72. 10.1378/chest.117.4.1162, 10767254.
40. Kane LP, Andres PG, Howland KC, Abbas AK, Weiss A. Akt provides the CD28 costimulatory signal for up-regulation of IL-2 and IFN-gamma but not TH2 cytokines. Nat Immunol 2001, 2:37-44. 10.1038/83144, 11135576.
41. Cheadle C, Fan J, Cho-Chung YS, Werner T, Ray J, Do L, Gorospe M, Becker KG. Control of gene expression during T cell activation: alternate regulation of mRNA transcription and mRNA stability. BMC Genomics 2005, 6:75. 10.1186/1471-2164-6-75, 1156890, 15907206.
42. Roggia C, Gao Y, Cenci S, Weitzmann MN, Toraldo G, Isaia G, Pacifici R. Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo. Proc Natl Acad Sci USA 2001, 98:13960-5. 10.1073/pnas.251534698, 61149, 11717453.
43. Dinarello CA. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest 1997, 112:321S-329S. 10.1378/chest.112.6_Supplement.321S, 9400897.
44. Groux H, Bigler M, de Vries JE, Roncarolo MG. Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J Exp Med 1996, 184:19-29. 10.1084/jem.184.1.19, 2192687, 8691133.
45. Jain J, Valge-Archer VE, Sinskey AJ, Rao A. The AP-1 site at -150 bp, but not the NF-kappa B site, is likely to represent the major target of protein kinase C in the interleukin 2 promoter. J Exp Med 1992, 175:853-62. 10.1084/jem.175.3.853, 2119150, 1740667.
46. Brown K, Park S, Kanno T, Franzoso G, Siebenlist U. Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha. Proc Natl Acad Sci USA 1993, 90:2532-6. 10.1073/pnas.90.6.2532, 46122, 8460169.
47. Scharschmidt E, Wegener E, Heissmeyer V, Rao A, Krappmann D. Degradation of Bcl10 induced by T-cell activation negatively regulates NF-kappa B signaling. Mol Cell Biol 2004, 24:3860-73. 10.1128/MCB.24.9.3860-3873.2004, 387748, 15082780.
48. Ebinu JO, Stang SL, Teixeira C, Bottorff DA, Hooton J, Blumberg PM, Barry M, Bleakley RC, Ostergaard HL, Stone JC. RasGRP links T-cell receptor signaling to Ras. Blood 2000, 95:3199-203.
49. Berry N, Nishizuka Y. Protein kinase C and T cell activation. Eur J Biochem 1990, 189:205-14. 10.1111/j.1432-1033.1990.tb15478.x, 2186905.
50. Manicassamy S, Sadim M, Ye RD, Sun Z. Differential roles of PKC-theta in the regulation of intracellular calcium concentration in primary T cells. J Mol Biol 2006, 355:347-59. 10.1016/j.jmb.2005.10.043, 16309697.
51. Barnes PJ, Adcock IM. NF-kappa B: a pivotal role in asthma and a new target for therapy. Trends Pharmacol Sci 1997, 18:46-50. 10.1016/S0165-6147(97)89796-9, 9090308.
52. Makarov SS. NF-kappaB as a therapeutic target in chronic inflammation: recent advances. Mol Med Today 2000, 6:441-8. 10.1016/S1357-4310(00)01814-1, 11074370.
53. Tergaonkar V. NFkappaB pathway: a good signaling paradigm and therapeutic target. Int J Biochem Cell Biol 2006, 38:1647-53. 10.1016/j.biocel.2006.03.023, 16766221.
54. Dolcet X, Llobet D, Pallares J, Matias-Guiu X. NF-kB in development and progression of human cancer. Virchows Arch 2005, 446:475-82. 10.1007/s00428-005-1264-9, 15856292.